Monday, January 26, 2009

All of a sudden pundits "love" the Pfizer-Wyeth deal . . .

Many of them hated the deal last week.

See for example 5 Reasons Pfizer Shouldn't Buy Wyeth or Fortune writer, John Simons who penned the article, “Why a Pfizer-Wyeth merger is a bad idea.”

Funny what a difference a weekend can make.

1 comment:

Anonymous said...

The analysts who think Wy-Pfi is a good thing are almost certainly the same ones who thought lending money they didn't have to people who couldn't pay it back was a good thing...